Skip to main content

Neuromuscular-Junction-on-a-Chip to study medication for Parkinson

Objective

While Europe is still missing publishing researchers working on brain-a-chip devices, scientists and pharmaceutical companies growing interests in investing in organ-on-a-chip devices urges because these lab-on-a-chip devices offer highly accessible systems for proof-reading and testing hypothesis-driven research. Chips allow ultra low-cost test benches for medication and offer flexibility to healthcare. This biotechnology set the first milestone for bio-prosthesis and in situ implants.

In the scope of this H2020 MSCA Fellowship, I propose to elaborate a neuromuscular-junction-on-a-chip, induce Parkinson with the well known α-synuclein and proactively test medication proposed by Novartis and Glaxosmithkline on the chip.

The proposed schematic is designed to bring closer academia and industry, research and innovation, from design to market. Elvesys, microfluidic center innovation in Paris is the beneficiary of this H2020 MSCA Fellowship. Elvesys team is creating a microfluidic valley in France, with the vision focus on Regenerative Medicine. During this project, I am aiming at improving Europe's stance as a leading organisation in bioengineering and an attractive destination for research.

Field of science

  • /social sciences/economics and business/business and management/commerce
  • /medical and health sciences/basic medicine/pharmacology and pharmacy/pharmaceutical drug
  • /medical and health sciences/basic medicine/neurology/parkinson
  • /medical and health sciences/medical biotechnology/medical bioproducts/implants

Call for proposal

H2020-MSCA-IF-2018
See other projects for this call

Funding Scheme

MSCA-IF-EF-SE - Society and Enterprise panel

Coordinator

ELVESYS
Address
172 Rue De Charonne B2 2 Eme Etage
75011 Paris
France
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 184 707,84